Tuberculous pericarditis is uncommon in the Western world, and can prove a diagnostic quandary in that confirmation of the diagnosis and culture of mycobacteria can be difficult. We present a case of tuberculous pericarditis where endobronchial ultrasound-guided transbronchial needle biopsy of a pathological lymph node provided the diagnosis after other methods of investigation had proved futile.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1258/smj.2011.011176 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tuberculous pericarditis in a 71-year-old immunocompetent patient: Case report.
IDCases
November 2024
Doctor of Medicine and Surgery, Hospital Escuela Universitario, Honduras.
Tuberculosis is a transmissible disease caused by the bacterium . It is the leading cause of mortality due to infectious diseases. Tuberculous pericarditis is one of the manifestations of extrapulmonary tuberculosis and represents the primary cause of pericardial effusion in developing countries.
View Article and Find Full Text PDFPericardial effusion in an Indian context: clinical insights and dynamics from a tertiary care centre.
BMC Cardiovasc Disord
December 2024
Faculty of General Medicine, Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Background: Pericardial effusion (PE) indicates the build-up of fluid within the pericardial sac, which encases the heart. The present study was undertaken to assess the clinical profile, etiology of pericardial effusion and to determine the correlation of cardiac tamponade and constrictive pericarditis with etiology.
Methods: A prospective observational hospital based longitudinal study was undertaken among the 88 newly diagnosed and known patients of pericardial effusion who are above 18 years.
Successful diagnosis and surgical treatment of tuberculous pericarditis.
Eur Heart J
December 2024
Department of Cardiology, Wuhan NO.1 Hospital, Wuhan 430014, China.
Tuberculous Pericarditis in an Immunocompromised Patient: A Case Report.
Cureus
October 2024
Cardiology, King Abdulaziz Medical City, King Abdulaziz Cardiac Center, Ministry of National Guard Health Affairs, Riyadh, SAU.
Article Synopsis
- A 43-year-old male with a history of chronic severe pericarditis, right-sided heart failure, and rheumatoid arthritis presented with chest pain, dyspnea, ascites, and limb edema.
- Diagnostic tests revealed significant pericardial thickening and necrotic lymph nodes, with a positive QuantiFERON-TB test confirming tuberculous pericarditis (TBP).
- The patient was treated with anti-tuberculosis therapy and a radical pericardiectomy, highlighting the need for prompt diagnosis and management to enhance patient outcomes in TBP cases.
promising immunotherapeutic intervention for diseases.
Front Immunol
November 2024
Department of Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States.
Immunomodulating agents interact with the immune system and alter the outcome of specific immune processes. As our understanding of the immune system continues to evolve, there is a growing effort to identify agents with immunomodulating applications to use therapeutically to treat various diseases. (Mw), a heat-killed mycobacterium, is an atypical mycobacterial species that possesses strong immunomodulatory properties.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!